Quethera

Quethera, headquartered in the Babraham Research Campus in Cambridge, UK, is a gene therapy company dedicated to improving future treatments for common blinding eye diseases. The company was co-founded in 2013 by Dr. Peter Widdowson (Quethera CEO) and Professor Keith Martin (Professor at the University of Cambridge and Head of Ophthalmology at the Department of Clinical Neurosciences).